| abstract |
The invention falls within the fields of virology and molecular biology, especially as applied to medical diagnostics and therapy. The invention relates to a method for assessing a risk of having or developing a cervical cancer comprising detecting or quantifying a number of integrations of HPV DNA into, or an integration pattern of HPV DNA in, genomic host DNA obtained from a patient or subject, thereby assessing the risk of having or developing cervical cancer. |